200nm Silica Magnetic Beads AMS200-10 5%

200nm Silica Magnetic Beads AMS200-10

AMS200-10 is a 200nm silica-coated magnetic bead suspension supplied at 5% solids.

When the solids content is expressed as weight per volume, 5% corresponds to approximately 50mg of magnetic bead material per milliliter. The concentration basis should be confirmed in the applicable product technical data sheet.

The silica surface provides a chemically adaptable platform for subsequent silanization, surface functionalization and biomolecule immobilization.

AMS200-10 can be evaluated as a magnetic base material for the development of antibody-functionalized particles, magnetic immunoassays, biomolecule capture, sample pretreatment, affinity separation and related life-science applications.

If AMS200-10 is supplied with a native silica or Si–OH surface, additional surface modification is generally required before stable covalent immobilization of antibodies, antigens, proteins or oligonucleotides.

Potential functionalized derivatives include amino, carboxyl, epoxy, aldehyde, tosyl, NHS-activated and streptavidin-coated magnetic particles.

AMS200-10 is intended for biotechnology companies, immunoassay developers, research institutions and reagent manufacturers requiring a concentrated 200nm silica magnetic bead raw material for feasibility evaluation, surface-chemistry development, pilot production and bulk manufacturing.

The product is supplied as a research and reagent-development raw material. It is not supplied as a finished diagnostic reagent.

Product Overview

Silica-coated magnetic beads combine a magnetically responsive particle with an outer silica surface.

The magnetic component enables particle recovery under an external magnetic field, while the silica surface provides silanol groups that may be used as a starting point for additional chemical functionalization.

Commercial exact-200nm silica magnetic nanoparticles are available with native hydroxyl surfaces and concentrations up to 50mg/mL. Related products are also available with carboxyl, amino, tosyl and other functional groups for biomolecule conjugation.

AMS200-10 may be evaluated for:

• Silica-surface functionalization;

• Antibody immobilization after surface modification;

• Antigen and protein immobilization;

• Magnetic immunoassay carrier development;

• Magnetic sandwich immunoassay research;

• Competitive immunoassay research;

• Sample pretreatment;

• Biomolecule enrichment;

• Affinity separation;

• Nucleic acid probe immobilization;

• Biosensor development;

• Pilot-scale reagent development;

• Batch manufacturing.

The final surface chemistry and coupling route should be selected according to the ligand, assay format, sample matrix and required storage stability.

AMS200-10 Product Specifications

The following product-specific parameters should be confirmed through the applicable TDS and lot-specific CoA:

• Mean particle diameter;

• Particle-size distribution;

• Polydispersity index;

• Particle morphology;

• Silica-shell structure;

• Magnetic core composition;

• Magnetic material content;

• Saturation magnetization;

• Magnetic collection time;

• Solids content;

• Surface silanol density;

• Suspension medium;

• Surfactant content;

• Preservative system;

• Storage temperature;

• Shelf life;

• Lot-release specifications.

Published competitor specifications should only be used for benchmarking. They should not be presented as AMS200-10 performance data.

What Are Silica-Coated Magnetic Beads?

Silica-coated magnetic beads are magnetic particles with an outer layer containing silica or silica-based material.

The silica layer can provide:

• A hydrophilic inorganic surface;

• Surface silanol groups;

• Chemical stability in many aqueous formulations;

• A platform for silane-based surface modification;

• A barrier between the magnetic material and the surrounding solution;

• A basis for introducing functional coupling groups.

Exact-200nm silica-coated magnetic nanoparticles are commercially offered with hydroxyl surfaces for chemical functionalization and biomolecule separation. Functionalized 200nm silica magnetic beads are also available with carboxyl, amino and tosyl groups for protein, antibody and oligonucleotide conjugation.

Native silica and functionalized silica should not be treated as the same coupling surface.

A native silica surface may require silanization or another modification step before covalent attachment of a biological ligand.

Key Features of AMS200-10

Defined 200nm Particle Size

AMS200-10 provides a submicron magnetic particle format with a nominal diameter of 200nm.

Compared with larger micron-sized particles of similar composition, smaller particles generally provide:

• More particles per unit mass;

• Higher theoretical geometric surface area per unit mass;

• Slower gravity-driven settling;

• Greater sensitivity to colloidal formulation;

• Greater dependence on magnetic material content and separator design.

The actual performance depends on particle density, magnetic loading, silica-shell thickness, aggregation state and buffer composition.

Concentrated 5% Solids Suspension

When expressed as w/v, 5% solids corresponds to approximately 50mg/mL.

Approximate bead-mass calculations are:

• 10µL contains approximately 0.5mg;

• 20µL contains approximately 1mg;

• 100µL contains approximately 5mg;

• 200µL contains approximately 10mg;

• 1mL contains approximately 50mg.

These calculations should only be used after confirming that the concentration is expressed as w/v.

A concentrated stock may support flexible preparation of lower working concentrations, pilot production and bulk reagent manufacturing.

Adaptable Silica Surface

The silica surface can be used as a starting point for introducing functional groups such as:

• Amino groups;

• Carboxyl groups;

• Epoxy groups;

• Aldehyde groups;

• Thiol-reactive groups;

• Tosyl groups;

• NHS esters;

• Biotin;

• Streptavidin;

• Protein A or Protein G.

Commercial silica magnetic particle suppliers commonly provide native, amino and carboxyl derivatives to support different biomolecule-binding strategies.

Suitable for Surface-Chemistry Development

AMS200-10 may be used by research teams developing their own:

• Silanization process;

• Antibody-coupling chemistry;

• Blocking formulation;

• Storage buffer;

• Magnetic wash procedure;

• Immunoassay particle formulation.

Research-to-Production Supply

AMS200-10 can support:

• Initial material evaluation;

• Surface-functionalization screening;

• Antibody-coupling optimization;

• Immunoassay feasibility studies;

• Process characterization;

• Pilot manufacturing;

• Stability evaluation;

• Batch-consistency testing;

• Bulk raw-material procurement.

Why Choose 200nm Silica Magnetic Beads?

High Particle Number per Unit Mass

For particles with similar density and structure, a 200nm format provides substantially more individual particles per unit mass than micron-sized beads.

This may increase the number of available particle–analyte interactions in a suspension assay.

However, particle number alone does not determine functional binding capacity. Other important factors include:

• Silica-shell thickness;

• Surface-group density;

• Functionalization efficiency;

• Ligand size;

• Ligand orientation;

• Steric accessibility;

• Aggregation;

• Blocking formulation.

Slower Gravity-Driven Settling

Submicron particles generally remain suspended longer than larger magnetic beads.

This may support:

• More uniform sampling;

• Suspension-based target capture;

• Reduced short-term sedimentation;

• Small-volume assay development.

Nevertheless, long-term stability and dispensing uniformity must be verified using the actual formulation.

Flexible Surface Modification

Native silica can be chemically modified using suitable silane chemistry.

This allows researchers to develop different surface derivatives from a common magnetic particle platform.

Concentrated Starting Material

A 5% suspension may reduce the storage and handling volume required for pilot or bulk manufacturing.

The working concentration should be diluted and optimized according to the intended coupling reaction and immunoassay.

Important Magnetic Separation Tradeoff

Submicron magnetic particles may require a stronger magnet, a longer collection time or an optimized separator compared with larger micron-sized beads.

Competitor results differ significantly. Magnostics reports rapid separation for its own high-magnetization 200nm silica particles, while an Ocean NanoTech 200nm particle protocol indicates that magnetic collection may require several hours depending on magnet strength. These values are product-specific and demonstrate why AMS200-10 must have its own validated magnetic collection method.

Silica Surface Chemistry and Antibody Immobilization

Native Silica Surface

A native silica surface contains silanol groups.

These groups provide a starting point for chemical modification but do not automatically provide a standardized, ready-to-use antibody-coupling reaction.

Direct passive adsorption may occur under selected conditions, but it may result in:

• Variable antibody orientation;

• Partial desorption;

• Reduced biological activity;

• Higher nonspecific adsorption;

• Lower storage stability;

• Greater lot-to-lot variation.

For reagent-development and batch-manufacturing projects, a validated covalent immobilization route is generally preferable.

Functionalized Silica Surface

Silica can be modified to introduce reactive groups suitable for biomolecule immobilization.

Commercial 200–250nm magnetic silica products are available with native OH, amino and carboxyl surfaces, confirming that surface chemistry is a major product-selection factor.

Antibody Orientation

The coupling chemistry can influence how the antibody is presented on the bead surface.

Random coupling through multiple amino groups may provide a simple process but can produce mixed antibody orientations.

More controlled approaches may involve:

• Carbohydrate-directed antibody modification;

• Fc-selective chemistry;

• Protein A or Protein G intermediates;

• Biotin–streptavidin immobilization;

• Site-specific engineered tags.

The optimal strategy depends on antibody structure, target accessibility, assay sensitivity and manufacturing requirements.

Recommended Surface Functionalization Options

Amino Functionalization

An amino-silane may be used to introduce surface amino groups.

The resulting particles can be coupled through routes involving:

• Glutaraldehyde;

• NHS ester crosslinkers;

• Heterobifunctional crosslinkers;

• Other validated amine-reactive chemistry.

Commercial 200nm amine magnetic bead kits use specialized crosslinking chemistry for conjugating antibodies, proteins, peptides and oligonucleotides.

Carboxyl Functionalization

Carboxyl groups can be introduced onto the silica surface and activated using EDC/NHS chemistry.

This route is commonly used to couple primary amines present on:

• Antibodies;

• Antigens;

• Proteins;

• Peptides;

• Amino-modified oligonucleotides.

Commercial 200nm carboxyl magnetic particles use this strategy for biomolecule conjugation and immunoassay development.

Epoxy Functionalization

Epoxy surfaces may react with amino, thiol or hydroxyl groups under suitable conditions.

This route may offer stable covalent immobilization but normally requires careful optimization of:

• pH;

• Ionic strength;

• Reaction time;

• Temperature;

• Ligand concentration;

• Blocking conditions.

Aldehyde Functionalization

Aldehyde groups can react with primary amines on proteins.

The resulting Schiff-base intermediate may require a validated reduction step to improve bond stability.

Tosyl Functionalization

Tosyl surfaces can react with amino- or thiol-containing biomolecules without a separate carbodiimide activation step.

Commercial 200nm tosyl silica magnetic particles are marketed for antibody, protein, peptide and oligonucleotide conjugation.

Streptavidin Functionalization

A streptavidin coating can provide a flexible affinity surface for biotinylated antibodies, antigens and oligonucleotides.

This approach separates the particle-manufacturing process from the final capture-ligand selection.

Applications in Immunoassay Development

Magnetic Sandwich Immunoassays

After suitable surface functionalization and antibody immobilization, AMS200-10 may be evaluated as a magnetic solid phase in sandwich immunoassays.

A typical assay includes:

1. Immobilize the capture antibody.

2. Incubate the antibody-coated particles with the sample.

3. Capture the target antigen.

4. Add a labelled detection antibody.

5. Magnetically separate and wash the complex.

6. Generate the analytical signal.

Chemiluminescence Immunoassay Research

Functionalized AMS200-10 may be evaluated for magnetic-particle chemiluminescence immunoassay development.

Magnetic-particle CLIA combines magnetic separation, immunorecognition and chemiluminescent detection. Commercial MPCLIA developers commonly use carboxyl, amino, tosyl or streptavidin magnetic surfaces rather than untreated silica.

Important development variables include:

• Surface-functionalization route;

• Antibody-loading density;

• Degree of antibody activity retention;

• Bead dosage;

• Magnetic collection time;

• Washing efficiency;

• Blank signal;

• Signal-to-background ratio;

• Automated-platform compatibility.

Competitive Immunoassays

Functionalized particles may be coupled with:

• Small-molecule conjugates;

• Haptens;

• Antigens;

• Anti-analyte antibodies;

• Biotinylated capture ligands.

This format can be evaluated when the analyte cannot support a conventional sandwich structure.

Antibody-Detection Assays

A functionalized silica magnetic particle may be coated with an antigen to capture target antibodies from a sample.

Potential research areas include:

• Infectious-disease antibody assays;

• Autoantibody assays;

• Vaccine-response studies;

• Recombinant antigen screening.

Immunomagnetic Enrichment

Antibody-functionalized particles may be evaluated for enriching:

• Antigens;

• Proteins;

• Microorganisms;

• Extracellular particles;

• Other affinity-recognized targets.

Biosensor and Microfluidic Research

The 200nm format may also be evaluated in:

• Magnetic biosensors;

• Microfluidic target capture;

• Magnetic signal amplification;

• Particle-based optical assays;

• Sample-concentration workflows.

General Antibody Coupling Workflow

The following workflow is a development framework and is not a validated AMS200-10 protocol.

Step 1: Confirm the Native Surface

Determine whether AMS200-10 is supplied as:

• Native silica;

• Amino-functional silica;

• Carboxyl-functional silica;

• Another activated surface.

Do not select the coupling chemistry until the actual surface has been confirmed.

Step 2: Fully Redisperse the Beads

Mix the original suspension until homogeneous.

Possible methods include:

• Gentle inversion;

• Roller mixing;

• Controlled vortexing;

• Bath sonication;

• Another validated dispersion method.

Sonication conditions should be validated because excessive energy may affect the surface coating, biomolecule activity or particle formulation.

Step 3: Wash or Equilibrate

Transfer the required particle quantity into a suitable buffer.

Magnetically collect the particles and replace the original suspension medium when required.

Because 200nm particles may collect more slowly than micron-sized beads, use a separator and collection time validated for the actual product.

Step 4: Functionalize the Silica Surface

Introduce the selected surface group using a controlled and validated process.

Monitor:

• Silane concentration;

• Water content;

• Solvent composition;

• pH;

• Reaction temperature;

• Reaction time;

• Particle concentration;

• Mixing;

• Washing.

Step 5: Activate the Functional Group

Examples include:

• EDC/NHS activation of carboxyl groups;

• Glutaraldehyde activation of amino groups;

• Epoxy coupling conditions;

• Tosyl coupling conditions;

• NHS ester preparation;

• Another validated activation route.

Step 6: Add the Antibody or Ligand

Evaluate several ligand-to-bead ratios.

Possible experimental groups include:

• Low loading;

• Medium loading;

• High loading;

• Different reaction times;

• Different pH conditions;

• Different temperatures.

Step 7: Maintain Uniform Mixing

Maintain the particles in suspension throughout the coupling reaction.

Avoid:

• Extended settling;

• Excessive foam;

• Strong shear;

• Uncontrolled temperature;

• Particle drying.

Step 8: Block Remaining Reactive Sites

Select a blocking reagent compatible with:

• The coupling chemistry;

• The antibody;

• The sample matrix;

• The downstream detection system.

Step 9: Wash the Conjugated Beads

Remove:

• Unbound antibody;

• Residual activating reagents;

• Side products;

• Unwanted proteins;

• Excess blocking reagent.

Step 10: Formulate the Final Suspension

The final formulation may include:

• Buffer;

• Salt;

• Surfactant;

• Protein stabilizer;

• Polymer stabilizer;

• Sugar or polyol;

• Preservative;

• Blocking component.

Step 11: Evaluate Functional Performance

Test:

• Antibody-loading efficiency;

• Functional target capture;

• Nonspecific binding;

• Blank signal;

• Positive signal;

• Magnetic recovery;

• Dispersion;

• Precision;

• Stability.

How to Optimize AMS200-10 for Immunoassays

Optimize the Surface Chemistry

Compare at least two functionalization routes when practical.

Possible comparison groups include:

• Amino versus carboxyl;

• Carboxyl versus epoxy;

• Covalent coupling versus streptavidin–biotin;

• Random antibody coupling versus oriented immobilization.

Optimize Antibody Loading

The highest antibody loading does not necessarily provide the best analytical result.

Excessive loading may cause:

• Steric crowding;

• Reduced antigen accessibility;

• Increased nonspecific adsorption;

• Particle bridging;

• Aggregation;

• Higher blank signal.

Optimize Particle Dosage

Too few particles may limit target capture.

Too many particles may increase:

• Reagent consumption;

• Nonspecific signal;

• Washing requirements;

• Residual particle interference;

• Magnetic collection time.

Optimize Blocking

Evaluate different blocking systems using the actual sample matrix.

Potential blockers include:

• Protein blockers;

• Synthetic polymers;

• Nonionic surfactants;

• Casein-derived formulations;

• Customer-developed blocking systems.

Optimize Magnetic Separation

Evaluate:

• Magnet strength;

• Separator geometry;

• Vessel geometry;

• Particle concentration;

• Sample volume;

• Buffer viscosity;

• Collection time;

• Residual liquid volume.

Optimize Dispersion

Evaluate:

• Surfactant type and concentration;

• Ionic strength;

• pH;

• Protein concentration;

• Mixing frequency;

• Sonication conditions;

• Freeze–thaw sensitivity.

200nm vs Micron-Sized Magnetic Beads

Particle size should not be selected alone.

Other important factors include:

• Magnetic content;

• Surface chemistry;

• Particle-size distribution;

• Antibody-loading density;

• Ligand activity;

• Nonspecific binding;

• Magnetic recovery;

• Instrument compatibility;

• Stability.

Magnetic Separation and Dispersion Optimization

Magnetic Collection Time

Do not assume that all 200nm magnetic beads separate at the same speed.

Magnetic collection depends on:

• Magnetic material content;

• Saturation magnetization;

• Particle concentration;

• Aggregation state;

• Magnet strength;

• Magnet distance;

• Vessel shape;

• Liquid viscosity;

• Sample volume.

Published competitor instructions range from rapid collection to several hours for different 200nm particle systems, demonstrating that collection time must be measured for AMS200-10 under standardized conditions.

Aggregation Control

Evaluate aggregation using an appropriate particle-size method.

Potential causes include:

• High ionic strength;

• pH near the particle’s isoelectric region;

• Incompatible proteins;

• Insufficient surfactant;

• Excessive antibody loading;

• Incomplete blocking;

• Repeated drying;

• Long exposure to the magnet.

Redispersion

After magnetic collection, evaluate:

• Ease of redispersion;

• Residual aggregates;

• Particle-size recovery;

• Functional antibody activity;

• Magnetic recovery after repeated cycles.

How to Evaluate Coupling and Assay Performance

Surface Functionalization

Possible tests include:

• Zeta potential;

• Surface-group titration;

• Elemental analysis;

• Spectroscopic analysis;

• Functional dye reaction;

• Another validated surface assay.

Antibody-Loading Efficiency

Measure the antibody concentration before and after coupling.

An approximate calculation is:

Loaded antibody = Initial antibody − Unbound antibody

Potential analytical methods include:

• UV absorbance;

• BCA assay;

• Bradford assay;

• Fluorescence measurement;

• ELISA;

• Another validated protein assay.

Functional Target Capture

Chemical antibody loading does not prove that the immobilized antibody remains active.

Functional testing should measure:

• Target-capture capacity;

• Positive signal;

• Negative signal;

• Signal-to-background ratio;

• Recovery;

• Specificity.

Nonspecific Binding

Compare:

• Unmodified silica particles;

• Functionalized but unconjugated particles;

• Antibody-conjugated particles;

• Blocked particles;

• Negative sample matrices;

• Positive samples.

Magnetic Recovery

Determine particle recovery after:

• Initial collection;

• Repeated washing;

• Extended incubation;

• Automated handling;

• Storage.

Immunoassay Performance

Evaluate:

• Blank signal;

• Low-positive signal;

• High-positive signal;

• Precision;

• Recovery;

• Linearity;

• Specificity;

• Hook effect;

• Interference;

• Stability.

Quality Control for Batch Production

Physical Quality Control

Recommended items include:

• Appearance;

• Particle size;

• Particle-size distribution;

• Polydispersity;

• Solids content;

• Suspension uniformity;

• Sedimentation behaviour;

• Redispersion.

Silica-Surface Quality Control

Recommended items include:

• Silica-shell consistency;

• Surface silanol availability;

• Surface-group density after modification;

• Surface charge;

• Functionalization yield;

• Residual chemical reagents.

Magnetic Quality Control

Standardize:

• Magnet type;

• Vessel;

• Particle concentration;

• Sample volume;

• Buffer viscosity;

• Collection time;

• Residual particle concentration.

Functional Quality Control

After surface modification, evaluate:

• Antibody-loading capacity;

• Functional antibody activity;

• Nonspecific binding;

• Target-capture performance;

• Immunoassay signal;

• Stability.

Lot-to-Lot Consistency

For batch manufacturing, establish acceptance ranges for:

• Particle size;

• Solids content;

• Surface chemistry;

• Magnetic collection;

• Dispersion;

• Coupling performance;

• Functional assay results.

Final raw-material approval should be based on the complete customer coupling and assay workflow.

Scale-Up and Bulk Supply

Evaluation Stage

Evaluation quantities can support:

• Surface-functionalization screening;

• Coupling-chemistry comparison;

• Antibody-loading optimization;

• Magnetic-separation testing;

• Initial immunoassay development.

Pilot-Scale Stage

Pilot quantities can support:

• Process confirmation;

• Mixing studies;

• Reaction-vessel evaluation;

• Washing-process development;

• Stability testing;

• Filling-process evaluation.

Batch-Production Stage

Bulk-supply planning may include:

• Annual demand;

• Packaging volume;

• Product concentration;

• Particle specifications;

• Technical documents;

• Quality documents;

• Reserved-lot requirements;

• Change-control requirements;

• Safety-stock planning.

Scale-Up Considerations

A laboratory surface-modification process should not be scaled only by multiplying reagent volumes.

Revalidate:

• Vessel geometry;

• Mixing efficiency;

• Particle homogeneity;

• Reagent-addition sequence;

• Silanization conditions;

• Reaction temperature;

• Washing efficiency;

• Magnetic collection;

• Process hold time;

• Final filling uniformity.

Custom Silica Magnetic Bead Services

SHBC can evaluate customized silica magnetic bead requirements for biotechnology companies, research institutions and reagent manufacturers.

Potential customization options include:

• Alternative particle sizes;

• Customized solids content;

• Amino-functional surfaces;

• Carboxyl-functional surfaces;

• Epoxy-functional surfaces;

• Aldehyde-functional surfaces;

• Tosyl-functional surfaces;

• Streptavidin-coated surfaces;

• Customer-specific surface-group density;

• Customized suspension buffer;

• Customized packaging volume;

• Pilot-scale manufacturing;

• Bulk manufacturing;

• OEM and private-label packaging;

• Customer-specific quality testing.

Customization feasibility depends on the requested specification, intended application, validation requirements and order quantity.

Storage and Handling Recommendations

Store AMS200-10 according to the product label, TDS and lot-specific CoA.

General handling recommendations include:

• Mix thoroughly before sampling;

• Use clean and calibrated equipment;

• Maintain suspension uniformity during dispensing;

• Avoid allowing the particles to dry;

• Avoid freezing unless specifically validated;

• Prevent microbial and chemical contamination;

• Avoid prolonged exposure to a strong magnetic field;

• Confirm compatibility before buffer exchange;

• Validate sonication conditions before routine use;

• Record the product lot number;

• Evaluate functionalized-bead stability separately.

Commercial silica-coated magnetic nanoparticle suppliers commonly recommend preventing freezing and maintaining a uniform suspension before use. Product-specific conditions for AMS200-10 must be confirmed using its own technical documentation.

Frequently Asked Questions

What is AMS200-10?

AMS200-10 is a 200nm silica-coated magnetic bead suspension supplied at 5% solids for surface-functionalization research, magnetic carrier development, biomolecule immobilization and batch manufacturing.

What does 5% solids mean?

When expressed as w/v, 5% solids corresponds to approximately 50mg of magnetic bead material per milliliter. The concentration basis should be confirmed in the product TDS.

Is AMS200-10 supplied with a native silica surface?

The product surface should be confirmed in the applicable TDS. If supplied as native silica, the primary surface groups are expected to be silica-associated hydroxyl or silanol groups.

Can antibodies be coupled directly to AMS200-10?

Native silica is not automatically a standardized ready-to-use antibody-coupling surface. Stable covalent antibody immobilization normally requires a validated surface-functionalization and coupling process.

Which functional groups can be introduced onto silica?

Potential modifications include amino, carboxyl, epoxy, aldehyde, tosyl, NHS, biotin and streptavidin surfaces.

Can AMS200-10 be used for immunoassay development?

Yes, it can be evaluated as a magnetic base material for immunoassay development after suitable surface functionalization and antibody or antigen immobilization.

Can AMS200-10 be evaluated for CLIA?

Functionalized AMS200-10 may be evaluated for chemiluminescence immunoassay research. Magnetic collection, washing, signal background and analyzer compatibility must be validated.

Why choose a 200nm particle size?

The 200nm format generally provides more particles and more theoretical surface area per unit mass than micron-sized particles, while showing slower settling. Magnetic collection may require more optimization.

How do 200nm beads differ from 1µm beads?

Compared with similar 1µm beads, 200nm particles generally provide more individual particles per unit mass and slower settling, but may be more sensitive to aggregation and magnetic-separation conditions.

How fast can AMS200-10 be magnetically separated?

The collection time depends on the magnetic content, magnet strength, particle concentration, vessel geometry, liquid viscosity and aggregation state. A product-specific method must be established.

Can AMS200-10 be sonicated?

Bath sonication or another dispersion method may be evaluated, but the permitted energy, duration and temperature should be confirmed using product-specific validation.

What coupling route is recommended for antibodies?

The preferred route depends on the functionalized surface. Examples include EDC/NHS for carboxyl surfaces, glutaraldehyde or crosslinkers for amino surfaces, and direct reactions for epoxy or tosyl surfaces.

Does more antibody always improve assay sensitivity?

No. Excessive antibody loading can cause steric crowding, aggregation, reduced antigen accessibility and higher nonspecific signal.

How can antibody-loading efficiency be measured?

Compare the initial antibody quantity with the unbound antibody remaining in the post-coupling supernatant. Functional target-capture performance should also be measured.

How can aggregation be reduced?

Evaluate pH, ionic strength, surfactant concentration, protein concentration, blocking formulation, mixing conditions and particle-loading density.

Can AMS200-10 be used with automated analyzers?

It may be evaluated for automated or semi-automated systems. Magnetic collection, dispensing, washing, redispersion and fluidic compatibility must be validated on the specific platform.

Is AMS200-10 a finished immunoassay reagent?

No. AMS200-10 is supplied as a raw material for research and reagent development. The customer is responsible for surface modification, ligand immobilization and validation of the finished reagent.

Are evaluation and bulk quantities available?

Evaluation, pilot and bulk-supply requirements can be discussed according to the intended surface chemistry, application and annual demand.

Can SHBC provide functionalized silica magnetic beads?

Customized amino, carboxyl, epoxy, tosyl, streptavidin and other surface options may be evaluated according to the required specifications and order quantity.

Request a Sample or Bulk Quotation

Contact SHBC to request an evaluation sample, technical information or bulk quotation for AMS200-10 200nm Silica Magnetic Beads.

Please provide:

• Intended immunoassay or separation application;

• Required surface chemistry;

• Antibody, antigen, protein or other ligand;

• Ligand molecular weight;

• Preferred coupling chemistry;

• Sample matrix;

• Magnetic separator or analyzer;

• Required evaluation quantity;

• Estimated pilot quantity;

• Expected annual demand;

• Preferred packaging volume;

• Required technical documents;

• Required quality documents;

• Target development schedule;

• Custom specification requirements.

SHBC supports silica magnetic bead projects from raw-particle evaluation and surface-functionalization development to antibody immobilization, pilot validation and bulk manufacturing.